BRAF and glioblastoma: Recent studies have demonstrated that the mutation of BRAF in V600E was detected in GBM, especially frequently in E-GBM which is a new defined pathological subtype of GBM according to WHO 2016 criteria (22–27), and a histological pattern of “GBM, IDH-wildtype” in the WHO classification in 2021 (28).